Related Experiment Video
Updated: Aug 20, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Silencing of c-myc expression in tumor cells by siRNA
T O Kabilova1, E L Chernolovskaya, A V Vladimirova
1Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia. pimanova@mail.ru
Abstract:
Suppression of c-myc protooncogene expression in KB-3-1 cells by siRNA was investigated. The siRNA duplex targeted to the exon 3 of c-myc mRNA was prepared by in vitro transcription with T7 RNA polymerase on short dsDNA-templates. It was found that incubation of KB-3-1 cells in the presence of 75 nM siRNA results in decrease of the c-myc mRNA level down to 5% of the level in the control cells and significant decline of KB-3-1 cell proliferation rate. Using 200 nM siRNA four-fold decrease of KB-3-1 cells proliferation rate was observed and this effect was stable at least 96 h after transfection.
Insights
Small interfering RNA (siRNA) effectively suppressed c-myc protooncogene expression in KB-3-1 cells, significantly reducing cell proliferation. This demonstrates siRNA
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- The c-myc protooncogene plays a crucial role in cell proliferation and is often dysregulated in cancer.
- Targeting oncogene expression is a key strategy in cancer therapy.
Purpose of the Study:
- To investigate the efficacy of small interfering RNA (siRNA) in suppressing c-myc protooncogene expression in KB-3-1 cells.
- To evaluate the impact of c-myc suppression on KB-3-1 cell proliferation.
Main Methods:
- siRNA duplexes targeting c-myc mRNA exon 3 were synthesized using in vitro transcription.
- KB-3-1 cells were incubated with varying concentrations of siRNA (75 nM and 200 nM).
- c-myc mRNA levels and cell proliferation rates were measured post-transfection.
Main Results:
- Incubation with 75 nM siRNA reduced c-myc mRNA levels to 5% of control levels.
- A significant decline in KB-3-1 cell proliferation was observed with siRNA treatment.
- Using 200 nM siRNA resulted in a four-fold decrease in proliferation, with effects sustained for at least 96 hours.
Conclusions:
- siRNA is an effective tool for suppressing c-myc protooncogene expression in KB-3-1 cells.
- Downregulation of c-myc significantly inhibits KB-3-1 cell proliferation.
- Sustained inhibition of proliferation suggests potential therapeutic applications for siRNA in targeting c-myc-driven cancers.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Induced Pluripotent Stem Cells
Somatic cells are...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Abnormal Proliferation

